G. Cavaglione

Systemic chemotherapy with FOLFOX in metastatic grade 1/2 neuroendocrine cancer

P. Niccoli, L. Mineur, J. Raoul, 2016, Molecular and clinical oncology.

Efficacy of FOLFOX Chemotherapy in Metastatic Enteropancreatic Neuroendocrine Tumors

P. Niccoli, L. Mineur, J. Raoul, 2021, AntiCancer Research.

Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal

K. Bénézery, E. François, A. Falk, 2019, Cancer medicine.

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

P. Couzigou, M. Ducreux, C. Borel, 2018, European journal of cancer.

Results of age-dependent anal canal cancer treatment: a single centre retrospective study.

P. Follana, J. Gérard, K. Bénézery, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Phase II trial evaluating a docetaxel‐capecitabine combination as treatment for hormone‐refractory prostate cancer

S. Oudard, J. Ferrero, E. Chamorey, 2006, Cancer.

Influence of the comprehensive geriatric assessment (CGA) in elderly metastatic cancer patients. Analysis from a prospective cohort of 1048 patients.

G. Poissonnet, S. Gonfrier, E. Benizri, 2016 .

Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience

P. Follana, K. Bénézery, E. François, 2017, Diseases of the colon and rectum.

Effectiveness and Tolerability of Maintenance Capecitabine Administrated to Patients with Metastatic Pancreatic Cancer Treated with First-Line FOLFIRINOX

P. Follana, J. Gal, E. François, 2015, Oncology.

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer.

O. Bouché, A. Bedjaoui, F. Retornaz, 2018, European journal of cancer.